| Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis (NCT05006573) | AstraZeneca | 2021-07-21 |
| A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation (NCT04656275) | Boehringer Ingelheim | 2021-03-04 |
| A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT04594369) | Insmed Incorporated | 2020-12-01 |
| Roflumilast in Non-CF Bronchiectasis Study (2019) (NCT04322929) | The University of Hong Kong | 2020-11-12 |
| A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis (NCT04010799) | Chiesi Farmaceutici S.p.A. | 2019-05-27 |
| Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis (NCT04278040) | Federal State Budgetary Institution, Pulmonology Scientific Research Institute | 2018-06-20 |
| Roflumilast in Non-CF Bronchiectasis Study (NCT03428334) | The University of Hong Kong | 2018-05-10 |
| Exercise Capacity in Non-cystic Fibrosis Bronchiectasis After a Pulmonary Rehabilitation Home-based Program (NCT05369624) | Hospital Universitario Virgen Macarena | 2018-05-08 |
| Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. (NCT03460704) | Zambon SpA | 2018-01-29 |
| Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT03218917) | Insmed Incorporated | 2017-10-31 |
| Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB) (NCT06877091) | University of Leeds | 2017-07-01 |
| Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) (NCT03093974) | Zambon SpA | 2017-06-06 |
| Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection (NCT02712983) | Novartis Pharmaceuticals | 2017-02-08 |
| A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects (NCT03056326) | Chiesi Farmaceutici S.p.A. | 2016-11-01 |
| The Role of Pulmonary Rehabilitation and Airways Clearance Techniques in the Multidisciplinary Management of Non CF Bronchiectasis (NCT02614300) | Hospital Clinic of Barcelona | 2015-11-01 |
| The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis (NCT02883101) | All India Institute of Medical Sciences | 2015-06-01 |
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) (NCT02104245) | Aradigm Corporation | 2014-05-28 |
| Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis (NCT02088216) | Qilu Hospital of Shandong University | 2014-04-01 |
| Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) (NCT01515007) | Aradigm Corporation | 2014-03-31 |
| Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis (NCT02081963) | Qilu Hospital of Shandong University | 2014-03-01 |
| Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1" (NCT00889967) | Aradigm Corporation | 2010-02-01 |
| The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis Bronchiectasis (NCT01792440) | Universitaire Ziekenhuizen KU Leuven | 2009-09-01 |
| Mortality in Non-cystic Fibrosis Bronchiectasis (NCT01792427) | Universitaire Ziekenhuizen KU Leuven | 2006-06-01 |
| An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis (NCT05344508) | Insmed Incorporated | |